Advent Healthcare & Life Sciences III Limited Partnership

This profile gathers the share dealings of Advent Healthcare & Life Sciences III Limited Partnership in Aegerion Pharmaceuticals, Inc. The record holds 13 filings, for trades running from 27 October 2010 to 9 March 2012.

On the open market, the record shows 1 purchase worth €727k and 9 sales worth €1.5M. Taken together, the sales exceed the purchases by €791k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2012 to date brings no purchases and 4 sales.

The record was last updated on 14 March 2012 with an open-market sale (€479k) in Aegerion Pharmaceuticals, Inc. The last purchase on record was published on 27 October 2010, which is 5,857 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.